Administration of activating anti-CD44 monoclonal antibody H90 into NOD/SCID mice transplanted with human AML cells markedly reduced leukemic engraftment and induced blast differentiation (Jin et al., 2006). The gene discussed is CD44; the disease is acute myeloid leukemia.